Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin Tydings

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Pediatrics|December 27, 2019
Technology and precision therapy delivery in childhood cancerCaitlin Tydings, AeRang Kim
Advanced Drug Delivery Reviews|November 18, 2020
Emerging hyperthermia applications for pediatric oncologyCaitlin Tydings, Karun V Sharma, AeRang Kim, et al.
Neuro-Oncology Advances|October 4, 2021
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Pediatrics|December 27, 2019
Technology and precision therapy delivery in childhood cancerCaitlin Tydings, AeRang Kim
Advanced Drug Delivery Reviews|November 18, 2020
Emerging hyperthermia applications for pediatric oncologyCaitlin Tydings, Karun V Sharma, AeRang Kim, et al.
Neuro-Oncology Advances|October 4, 2021
Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1Caitlin Tydings, Pavel Yarmolenko, Miriam Bornhorst, et al.
Cancer Treatment Reviews|August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersSilvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
Pageof 1